Jing Jing Pharmaceutical Co., Ltd.

Jingjing Pharmaceutical Co., Ltd. was established in October 2007 and operates at No. 88 Jingyi Road in the Dacaozhuang Industrial Zone of Ningjin County, Xingtai City, Hebei Province. The site covers 310 mu, registered capital is 257.28 million yuan and the company employs more than 700 people.

Its work is split between sterile active pharmaceutical ingredients, where crystallisation is the core technology, and amino acid and vitamin nutritional fortifiers. The catalogue includes an aspartic acid series, a ketoglutaric acid series, amino acids and peptides, vitamins and an iminodiacetic acid series, which covers the alpha-ketoglutarate, beta-alanine, L-citrulline, L-carnosine and L-ornithine-L-aspartate materials the company supplies to the supplement trade.

The company listed on China's New Third Board in December 2015 under code 835033 and entered the innovation tier in the first batch. Three subsequent placements raised 240 million yuan, directed at research, extending the main product chain and working capital. The technical team holds 67 patents, 39 of them invention patents. It is a National High-Tech Enterprise and a national technological innovation demonstration enterprise, hosts a national and local joint engineering laboratory, a provincial enterprise technology centre and an academician workstation, and is recognised as a Hebei technological innovation demonstration enterprise.